6 results
8-K
EX-99.1
BHVN
Biohaven Ltd.
12 May 23
Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments
4:47pm
Kozauer, M.D. as SVP of Clinical Development and Regulatory Strategy following his tenure as Director of the Division of Neurology 2 in the Office … of Nick Kozauer, M.D. as SVP of Clinical Development and Regulatory Strategy following his tenure as Director of the Division of Neurology 2
424B4
BHVN
Biohaven Ltd.
24 Oct 22
Prospectus supplement with pricing info
9:38am
. During his tenure with BMS, Dr. Car contributed to progressing approximately 250 internally discovered drug candidates and over 18 drug registrations
S-1/A
BHVN
Biohaven Ltd.
20 Oct 22
IPO registration (amended)
10:00am
. During his tenure with BMS, Dr. Car contributed to progressing approximately 250 internally discovered drug candidates and over 18 drug registrations. Dr
S-1
BHVN
Biohaven Ltd.
18 Oct 22
IPO registration
4:03pm
a cohesive team of over 300 scientists and specialists covering biomarkers through data science and pharmaco-diagnostics. During his tenure with BMS, Dr
DRS
m6goo
11 Oct 22
Draft registration statement
12:00am
- Prev
- 1
- Next